Exploiting innate immunity for cancer immunotherapy.
Cancer immunotherapy
Chimeric antigen receptor
Dendritic cell
Innate immunity
Macrophage
Myeloid-derived suppressor cell
Natural killer cell
Neutrophil
Journal
Molecular cancer
ISSN: 1476-4598
Titre abrégé: Mol Cancer
Pays: England
ID NLM: 101147698
Informations de publication
Date de publication:
27 Nov 2023
27 Nov 2023
Historique:
received:
07
07
2023
accepted:
23
10
2023
medline:
28
11
2023
pubmed:
27
11
2023
entrez:
26
11
2023
Statut:
epublish
Résumé
Immunotherapies have revolutionized the treatment paradigms of various types of cancers. However, most of these immunomodulatory strategies focus on harnessing adaptive immunity, mainly by inhibiting immunosuppressive signaling with immune checkpoint blockade, or enhancing immunostimulatory signaling with bispecific T cell engager and chimeric antigen receptor (CAR)-T cell. Although these agents have already achieved great success, only a tiny percentage of patients could benefit from immunotherapies. Actually, immunotherapy efficacy is determined by multiple components in the tumor microenvironment beyond adaptive immunity. Cells from the innate arm of the immune system, such as macrophages, dendritic cells, myeloid-derived suppressor cells, neutrophils, natural killer cells, and unconventional T cells, also participate in cancer immune evasion and surveillance. Considering that the innate arm is the cornerstone of the antitumor immune response, utilizing innate immunity provides potential therapeutic options for cancer control. Up to now, strategies exploiting innate immunity, such as agonists of stimulator of interferon genes, CAR-macrophage or -natural killer cell therapies, metabolic regulators, and novel immune checkpoint blockade, have exhibited potent antitumor activities in preclinical and clinical studies. Here, we summarize the latest insights into the potential roles of innate cells in antitumor immunity and discuss the advances in innate arm-targeted therapeutic strategies.
Identifiants
pubmed: 38008741
doi: 10.1186/s12943-023-01885-w
pii: 10.1186/s12943-023-01885-w
pmc: PMC10680233
doi:
Substances chimiques
Immune Checkpoint Inhibitors
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
187Subventions
Organisme : China Postdoctoral Science Foundation
ID : 2022M722766
Organisme : National Natural Science Foundation of China
ID : 82072597
Organisme : National Natural Science Foundation of China
ID : 82073370
Informations de copyright
© 2023. The Author(s).
Références
Science. 2014 May 23;344(6186):921-5
pubmed: 24812208
Int J Cancer. 2012 Mar 1;130(5):1109-19
pubmed: 21480223
Front Immunol. 2020 Aug 04;11:1731
pubmed: 32849616
Cell. 2014 Apr 10;157(2):340-356
pubmed: 24725403
J Hematol Oncol. 2020 Jan 31;13(1):10
pubmed: 32005273
Int J Nanomedicine. 2021 Apr 07;16:2703-2714
pubmed: 33854316
Cell Rep. 2021 Oct 19;37(3):109844
pubmed: 34686340
Nat Rev Immunol. 2020 Jan;20(1):7-24
pubmed: 31467405
Mol Cancer. 2021 Feb 5;20(1):28
pubmed: 33546704
Cancer Cell. 2008 Oct 7;14(4):299-311
pubmed: 18835032
Exp Hematol Oncol. 2022 Jun 7;11(1):36
pubmed: 35672796
J Natl Cancer Inst. 2014 May 29;106(6):dju124
pubmed: 24875653
Sci Transl Med. 2015 Apr 15;7(283):283ra52
pubmed: 25877890
Eur J Cancer. 1993;29A(5):724-8
pubmed: 8471331
Nature. 2019 May;569(7754):73-78
pubmed: 30996346
Cancer Immunol Res. 2018 Oct;6(10):1186-1198
pubmed: 30108045
J Immunol. 2012 Apr 1;188(7):3150-9
pubmed: 22351936
Cancers (Basel). 2020 Aug 03;12(8):
pubmed: 32756356
J Leukoc Biol. 2006 Jun;79(6):1131-9
pubmed: 16617160
J Biomed Sci. 2019 Oct 20;26(1):78
pubmed: 31629410
J Biol Regul Homeost Agents. 2013 Jul-Sep;27(3):827-39
pubmed: 24152847
Clin Cancer Res. 2019 Jun 1;25(11):3289-3303
pubmed: 30755440
Immunity. 2010 Jun 25;32(6):803-14
pubmed: 20620944
Cancer Biol Ther. 2019;20(7):956-966
pubmed: 31062668
Expert Rev Anticancer Ther. 2021 Aug;21(8):841-851
pubmed: 33831324
Nat Commun. 2021 Mar 15;12(1):1669
pubmed: 33723257
Semin Immunol. 2015 Aug;27(4):267-75
pubmed: 26454572
Semin Cancer Biol. 2012 Aug;22(4):275-81
pubmed: 22313874
Mol Ther. 2019 Jun 5;27(6):1114-1125
pubmed: 30962163
Front Immunol. 2018 Sep 21;9:1990
pubmed: 30298063
Cancer Cell. 2016 Jun 13;29(6):832-845
pubmed: 27265504
Nat Rev Immunol. 2016 Feb;16(2):112-23
pubmed: 26806484
Med Oncol. 2018 Jan 31;35(3):24
pubmed: 29387968
Clin Cancer Res. 2021 Apr 15;27(8):2190-2199
pubmed: 33451977
Front Immunol. 2018 Nov 13;9:2629
pubmed: 30483271
J Hepatol. 2022 Sep;77(3):748-760
pubmed: 35378172
iScience. 2023 Jan 31;26(3):106081
pubmed: 36843852
Cancer Res. 2020 Jul 1;80(13):2874-2888
pubmed: 32265223
Mol Med Rep. 2016 May;13(5):4175-82
pubmed: 27035679
Front Immunol. 2020 Oct 15;11:575597
pubmed: 33178203
Semin Immunol. 2020 Apr;48:101407
pubmed: 32900565
Oncoimmunology. 2017 Jul 24;6(11):e1353858
pubmed: 29147601
Int J Mol Sci. 2022 Feb 17;23(4):
pubmed: 35216365
Cancers (Basel). 2021 Sep 16;13(18):
pubmed: 34572874
Science. 2018 Mar 23;359(6382):1355-1360
pubmed: 29567706
J Biol Regul Homeost Agents. 2014 Jan-Mar;28(1):81-90
pubmed: 24750794
Nat Med. 2020 Nov;26(11):1686-1690
pubmed: 33046868
Clin Rheumatol. 2018 Aug;37(8):2233-2240
pubmed: 29770930
Cancer Cell. 2023 Feb 13;41(2):272-287.e9
pubmed: 36706761
Exp Hematol Oncol. 2022 Nov 2;11(1):85
pubmed: 36324149
Front Immunol. 2018 Sep 20;9:2140
pubmed: 30294328
Cancer Res. 2003 Mar 15;63(6):1405-12
pubmed: 12649206
Eur Urol. 2019 May;75(5):752-763
pubmed: 30293904
Ther Adv Med Oncol. 2021 May 29;13:17588359211020529
pubmed: 34104228
Sci Transl Med. 2018 Jan 17;10(424):
pubmed: 29343622
Front Immunol. 2018 Aug 28;9:1969
pubmed: 30210505
Adv Mater. 2018 May;30(22):e1706245
pubmed: 29577477
Nat Med. 2000 Apr;6(4):443-6
pubmed: 10742152
J Hematol Oncol. 2021 Sep 15;14(1):146
pubmed: 34526097
Clin Cancer Res. 2007 Aug 15;13(16):4840-8
pubmed: 17699863
J Hematol Oncol. 2019 Mar 12;12(1):27
pubmed: 30866992
Int J Mol Sci. 2021 Jan 22;22(3):
pubmed: 33499253
Clin Cancer Res. 2008 Dec 15;14(24):8270-8
pubmed: 19088044
Cancer Immunol Res. 2021 Jan;9(1):50-61
pubmed: 33177109
Clin Cancer Res. 2016 Aug 1;22(15):3924-36
pubmed: 26957562
Clin Rev Allergy Immunol. 2014 Oct;47(2):119-27
pubmed: 24366573
Clin Cancer Res. 2020 Oct 15;26(20):5520-5533
pubmed: 32591463
Cell Rep. 2021 Jan 5;34(1):108597
pubmed: 33406434
Science. 2011 Mar 25;331(6024):1612-6
pubmed: 21436454
J Immunother Cancer. 2018 Nov 16;6(1):119
pubmed: 30446007
Immunity. 2021 Oct 12;54(10):2354-2371.e8
pubmed: 34614413
J Hematol Oncol. 2020 Jan 6;13(1):3
pubmed: 31907001
Cells. 2021 Jun 15;10(6):
pubmed: 34203915
Blood. 2012 Sep 6;120(10):2011-20
pubmed: 22791285
Adv Mater. 2021 Oct;33(43):e2103258
pubmed: 34510559
Immunity. 2008 Sep 19;29(3):372-83
pubmed: 18799145
Ann Oncol. 2022 Feb;33(2):169-180
pubmed: 34800678
Cancer Cell. 2019 Dec 9;36(6):613-629.e7
pubmed: 31761658
Proc Natl Acad Sci U S A. 2008 Nov 11;105(45):17481-6
pubmed: 18987320
N Engl J Med. 1987 Jun 11;316(24):1499-505
pubmed: 3295542
Annu Rev Pathol. 2022 Jan 24;17:425-457
pubmed: 34788549
Nature. 2014 Apr 17;508(7496):397-401
pubmed: 24509713
J Immunother Cancer. 2021 Oct;9(10):
pubmed: 34599028
Cancer Cell. 2021 Oct 11;39(10):1361-1374.e9
pubmed: 34478639
Clin Cancer Res. 2017 Sep 1;23(17):5187-5201
pubmed: 28698201
Cell Rep. 2018 Jun 26;23(13):3946-3959.e6
pubmed: 29949776
J Transl Med. 2015 Aug 25;13:277
pubmed: 26303618
Nat Med. 2018 Aug;24(8):1178-1191
pubmed: 29942093
Annu Rev Pathol. 2020 Jan 24;15:123-147
pubmed: 31530089
Biomed Pharmacother. 2022 Dec;156:113841
pubmed: 36411657
Front Immunol. 2017 Jun 01;8:637
pubmed: 28620389
J Hematol Oncol. 2023 Aug 12;16(1):94
pubmed: 37573354
J Exp Med. 2021 Feb 1;218(2):
pubmed: 33382402
Cytotherapy. 2013 Dec;15(12):1563-70
pubmed: 24094496
Cancer Immunol Res. 2017 May;5(5):347-354
pubmed: 28465452
Acta Oncol. 2017 Nov;56(11):1522-1530
pubmed: 28835188
Am J Dermatopathol. 2008 Feb;30(1):27-30
pubmed: 18212540
Signal Transduct Target Ther. 2021 Jan 8;6(1):8
pubmed: 33414388
Biochim Biophys Acta Rev Cancer. 2020 Dec;1874(2):188434
pubmed: 32956767
Cell Res. 2020 Nov;30(11):966-979
pubmed: 32839553
Nature. 2017 May 25;545(7655):495-499
pubmed: 28514441
Cancer Immunol Res. 2014 Jan;2(1):1-8
pubmed: 24778159
J Exp Med. 2006 Nov 27;203(12):2691-702
pubmed: 17101732
N Engl J Med. 2018 Nov 01;379(18):1711-1721
pubmed: 30380386
J Immunother Cancer. 2022 Mar;10(3):
pubmed: 35301236
Cancer Res. 2019 Jul 1;79(13):3360-3371
pubmed: 31043378
Blood. 2009 Sep 24;114(13):2667-77
pubmed: 19553639
Biomark Res. 2021 Jul 31;9(1):62
pubmed: 34332618
Theranostics. 2022 May 1;12(8):3776-3793
pubmed: 35664070
Cell. 2020 Feb 20;180(4):749-763.e13
pubmed: 32059780
Immunol Rev. 2018 Mar;282(1):8-34
pubmed: 29431214
Cancer Immunol Immunother. 2019 Jan;68(1):33-43
pubmed: 30251149
J Exp Med. 1993 Jul 1;178(1):1-16
pubmed: 8391057
Nat Commun. 2015 Apr 29;6:6840
pubmed: 25924227
Cancer Discov. 2016 Apr;6(4):400-413
pubmed: 26896096
J Immunol. 2012 Feb 15;188(4):1592-9
pubmed: 22231700
Cancer Res. 2015 Apr 15;75(8):1624-1634
pubmed: 25691457
Mol Cancer. 2022 Apr 23;21(1):104
pubmed: 35461253
Cancer Discov. 2019 Oct;9(10):1422-1437
pubmed: 31340937
Nat Immunol. 2016 Apr;17(4):356-63
pubmed: 27002843
JCI Insight. 2017 Sep 21;2(18):
pubmed: 28931759
Blood Cancer J. 2021 Apr 6;11(4):69
pubmed: 33824268
Cancer Cell. 2022 Sep 12;40(9):1027-1043.e9
pubmed: 36099881
Clin Cancer Res. 2009 Apr 15;15(8):2675-84
pubmed: 19336519
Haematologica. 2017 Jul;102(7):e266-e270
pubmed: 28385777
J Immunother Cancer. 2020 Oct;8(2):
pubmed: 33020239
J Immunol. 2013 Dec 1;191(11):5684-94
pubmed: 24184559
J Immunol. 1998 Jan 1;160(1):233-40
pubmed: 9551976
Cell. 2018 Dec 13;175(7):1731-1743.e13
pubmed: 30503213
Oncol Lett. 2017 Dec;14(6):7483-7488
pubmed: 29344192
J Immunother Cancer. 2022 Jun;10(6):
pubmed: 35688559
Cell Mol Immunol. 2022 Feb;19(2):177-191
pubmed: 35039631
Pharmacol Res. 2020 Jul;157:104881
pubmed: 32380052
J Immunol. 2005 May 15;174(10):6013-22
pubmed: 15879094
Trends Immunol. 2022 Dec;43(12):959-968
pubmed: 36441083
Clin Cancer Res. 2017 Aug 1;23(15):4107-4118
pubmed: 28280089
Immunity. 2008 Apr;28(4):571-80
pubmed: 18394936
Nat Commun. 2021 Feb 24;12(1):1270
pubmed: 33627655
Curr Pharm Des. 2009;15(16):1868-78
pubmed: 19519429
J Clin Oncol. 2015 Jan 1;33(1):74-82
pubmed: 25403209
Mediators Inflamm. 2014;2014:971409
pubmed: 24803743
PLoS One. 2013 May 21;8(5):e64281
pubmed: 23700468
Cancer Immunol Res. 2023 Feb 3;11(2):184-198
pubmed: 36478221
Blood. 2022 May 5;139(18):2782-2796
pubmed: 35231101
J Clin Invest. 2013 Sep;123(9):3925-40
pubmed: 23925295
Nat Med. 2007 Jul;13(7):828-35
pubmed: 17603493
Clin Cancer Res. 2012 Jan 15;18(2):499-509
pubmed: 22128302
J Hematol Oncol. 2021 Oct 21;14(1):173
pubmed: 34674757
J Hematol Oncol. 2022 Sep 17;15(1):135
pubmed: 36115986
Cell. 2021 Feb 4;184(3):792-809.e23
pubmed: 33545035
Cancer Cell Int. 2012 Jan 23;12(1):2
pubmed: 22270330
Cell Mol Biol (Noisy-le-grand). 2003 Nov;49(7):1009-16
pubmed: 14682382
Mol Ther Nucleic Acids. 2023 Jul 19;33:599-616
pubmed: 37637207
Blood. 2002 May 1;99(9):3263-71
pubmed: 11964292
J Hematol Oncol. 2021 Sep 23;14(1):152
pubmed: 34556152
Transl Oncol. 2010 Dec 01;3(6):354-61
pubmed: 21151474
Int J Cancer. 2000 Jan 15;85(2):171-5
pubmed: 10629073
Cancer Res. 2016 Mar 15;76(6):1367-80
pubmed: 26759232
Cancer Immunol Res. 2019 Oct;7(10):1687-1699
pubmed: 31439615
Immunity. 2015 Aug 18;43(2):394-407
pubmed: 26287684
J Immunother Cancer. 2021 Apr;9(4):
pubmed: 33837055
Br J Cancer. 2006 Apr 10;94(7):1029-34
pubmed: 16598185
J Immunol. 2012 Nov 1;189(9):4674-83
pubmed: 23028051
Science. 2019 May 10;364(6440):558-566
pubmed: 31000591
J Immunol. 2012 Mar 15;188(6):2509-15
pubmed: 22308311
Theranostics. 2016 Jun 15;6(9):1403-14
pubmed: 27375788
J Leukoc Biol. 2022 Oct;112(4):901-911
pubmed: 35088475
J Immunol. 2012 Oct 15;189(8):3878-93
pubmed: 22972928
J Immunol. 2007 Apr 1;178(7):4222-9
pubmed: 17371978
J Biomed Nanotechnol. 2020 Feb 1;16(2):212-223
pubmed: 32252882
Blood. 2008 Apr 15;111(8):4233-44
pubmed: 18272812
Nat Immunol. 2015 Jun;16(6):609-17
pubmed: 25915731
Cancer Immunol Immunother. 2012 Mar;61(3):385-96
pubmed: 21928126
Nat Rev Immunol. 2021 Sep;21(9):548-569
pubmed: 33833439
Cancer Immunol Res. 2014 Aug;2(8):725-31
pubmed: 24878583
J Immunother Cancer. 2021 Mar;9(3):
pubmed: 33692217
Exp Hematol Oncol. 2022 Sep 24;11(1):61
pubmed: 36153595
Curr Opin Immunol. 2020 Oct;66:114-122
pubmed: 32947131
J Exp Med. 2000 Feb 21;191(4):661-8
pubmed: 10684858
J Allergy Clin Immunol Pract. 2018 Sep - Oct;6(5):1439-1444
pubmed: 30197067
Clin Cancer Res. 2016 Nov 15;22(22):5487-5496
pubmed: 27185375
Cells. 2020 Mar 18;9(3):
pubmed: 32197382
Int Immunol. 2000 Jun;12(6):909-14
pubmed: 10837418
Front Immunol. 2020 May 21;11:924
pubmed: 32508825
Blood. 2023 Feb 23;141(8):869-876
pubmed: 36347021
Mol Ther. 2013 Mar;21(3):638-47
pubmed: 23295945
Trends Immunol. 2021 Mar;42(3):209-227
pubmed: 33495077
Adv Exp Med Biol. 2020;1224:21-34
pubmed: 32036602
Nat Commun. 2021 Jun 7;12(1):3414
pubmed: 34099731
Protein Cell. 2016 Feb;7(2):130-40
pubmed: 26797765
Immunity. 2004 Aug;21(2):279-88
pubmed: 15308107
Front Immunol. 2022 Dec 12;13:1056838
pubmed: 36578500
Nat Rev Mol Cell Biol. 2010 Mar;11(3):220-8
pubmed: 20177397
Breast Cancer Res Treat. 2015 Aug;153(1):21-30
pubmed: 26208484
MAbs. 2023 Jan-Dec;15(1):2208697
pubmed: 37165468
J Immunother Cancer. 2022 Dec;10(12):
pubmed: 36460337
Immunity. 2014 Nov 20;41(5):843-52
pubmed: 25517616
JAMA Oncol. 2017 Jul 01;3(7):969-973
pubmed: 28114604
Int Immunopharmacol. 2016 Oct;39:265-272
pubmed: 27497194
Blood. 2008 Jun 15;111(12):5467-76
pubmed: 18424663
Cancer Res. 2011 Apr 1;71(7):2411-6
pubmed: 21427354
Lung Cancer. 2017 Sep;111:176-181
pubmed: 28838390
Cancer Res. 2015 Mar 1;75(5):798-802
pubmed: 25660949
J Transl Med. 2016 Oct 12;14(1):288
pubmed: 27729044
J Exp Med. 2003 Aug 4;198(3):433-42
pubmed: 12900519
Oncotarget. 2016 Dec 13;7(50):83392-83408
pubmed: 27825135
Nat Immunol. 2022 Jul;23(7):993-995
pubmed: 35761086
Nat Rev Drug Discov. 2014 Jun;13(6):433-44
pubmed: 24833295
Exp Hematol Oncol. 2022 Jul 30;11(1):44
pubmed: 35907881
Nat Rev Drug Discov. 2018 Dec;17(12):887-904
pubmed: 30361552
Nat Immunol. 2016 Nov;17(11):1273-1281
pubmed: 27595232
J Immunother Cancer. 2022 Jul;10(7):
pubmed: 35831032
Nat Rev Cancer. 2023 Jun;23(6):351-371
pubmed: 37081117
J Exp Med. 2008 Sep 29;205(10):2235-49
pubmed: 18809714
Int J Cancer. 2016 Apr 15;138(8):1982-93
pubmed: 26619320
Clin Cancer Res. 2019 Oct 1;25(19):5799-5807
pubmed: 31320597
Cancer Cell. 2020 Mar 16;37(3):289-307.e9
pubmed: 32183949
Cell. 2020 Mar 19;180(6):1098-1114.e16
pubmed: 32169218
Cell. 2020 Mar 19;180(6):1044-1066
pubmed: 32164908
Nature. 2018 Dec;564(7736):439-443
pubmed: 30405246
Sci Transl Med. 2020 Mar 11;12(534):
pubmed: 32161104
Nat Rev Immunol. 2013 Jan;13(1):9-22
pubmed: 23154224
Nat Rev Cancer. 2019 Jul;19(7):392-404
pubmed: 31209264
Science. 2012 Apr 6;336(6077):86-90
pubmed: 22442384
Arch Pharm Res. 2014;37(9):1234-40
pubmed: 24748512
Redox Biol. 2019 Apr;22:101116
pubmed: 30769285
Proc Natl Acad Sci U S A. 2017 Dec 5;114(49):E10578-E10585
pubmed: 29158380
Int J Mol Sci. 2022 Mar 16;23(6):
pubmed: 35328639
Cancers (Basel). 2019 Apr 19;11(4):
pubmed: 31010242
Pharmacol Res. 2020 Sep;159:104980
pubmed: 32504832
Nature. 2014 Sep 25;513(7519):559-63
pubmed: 25043024
J Clin Oncol. 2004 Apr 15;22(8):1389-97
pubmed: 15084613
Front Immunol. 2022 May 02;13:840844
pubmed: 35585985
Immunol Rev. 2017 Mar;276(1):145-164
pubmed: 28258703
Cancer Treat Rev. 2018 Dec;71:88-101
pubmed: 30390423
Front Oncol. 2019 Nov 15;9:1146
pubmed: 31799175
J Leukoc Biol. 2018 Sep;104(3):473-486
pubmed: 29668066
Expert Opin Ther Targets. 2019 Oct;23(10):839-853
pubmed: 31524529
N Engl J Med. 2012 Jun 28;366(26):2443-54
pubmed: 22658127
Cell. 2019 Oct 31;179(4):829-845.e20
pubmed: 31675496
J Immunol. 2010 Dec 1;185(11):7067-76
pubmed: 21041732
Nanomedicine (Lond). 2017 Dec;12(23):2693-2706
pubmed: 29098928
J Hematol Oncol. 2020 Dec 7;13(1):168
pubmed: 33287875
J Immunother Cancer. 2022 Aug;10(8):
pubmed: 36002184
Clin Cancer Res. 2017 Jan 15;23(2):587-599
pubmed: 27401249
Clin Cancer Res. 1999 Oct;5(10):2963-70
pubmed: 10537366
Mol Ther Oncolytics. 2022 Jun 06;26:1-14
pubmed: 35784401
Annu Rev Immunol. 2017 Apr 26;35:285-311
pubmed: 28446061
J Zhejiang Univ Sci B. 2021 Dec 15;22(12):971-984
pubmed: 34904411
J Immunother Cancer. 2021 Jan;9(1):
pubmed: 33504575
Signal Transduct Target Ther. 2021 Oct 7;6(1):362
pubmed: 34620838
Sci Rep. 2022 Jul 15;12(1):12068
pubmed: 35840635
Oncoimmunology. 2017 Oct 20;7(1):e1375641
pubmed: 29296532
J Invest Dermatol. 2014 Apr;134(4):1091-1100
pubmed: 24226205
Oncotarget. 2015 Nov 17;6(36):39050-61
pubmed: 26375811
Nat Rev Drug Discov. 2020 Mar;19(3):200-218
pubmed: 31907401
Trends Cancer. 2016 Nov;2(11):664-675
pubmed: 28741505
Pharmacol Ther. 2022 Nov;239:108189
pubmed: 35430292
Cancer Res. 2011 Dec 15;71(24):7463-70
pubmed: 22025564
Int J Cancer. 2004 May 10;109(6):893-9
pubmed: 15027123
Nat Rev Clin Oncol. 2019 Mar;16(3):151-167
pubmed: 30523282
J Exp Med. 2011 Sep 26;208(10):2005-16
pubmed: 21930765
Br J Cancer. 2020 Mar;122(6):778-788
pubmed: 31932754
Mol Immunol. 2011 Sep;48(15-16):2087-93
pubmed: 21813181
Blood. 2014 Oct 30;124(18):2824-33
pubmed: 25049283
Nat Rev Clin Oncol. 2023 Mar;20(3):178-191
pubmed: 36624304
Gut. 2018 Jun;67(6):1112-1123
pubmed: 29196437
J Immunol. 2004 Nov 15;173(10):5909-13
pubmed: 15528322
Cancer Cell. 2016 Jul 11;30(1):108-119
pubmed: 27374223
Semin Immunol. 2018 Feb;35:29-34
pubmed: 29428698
Cells. 2020 Jul 07;9(7):
pubmed: 32645919
Neurosurg Rev. 2021 Dec;44(6):3471-3478
pubmed: 33765226
Int Immunopharmacol. 2011 Jul;11(7):890-8
pubmed: 21244860
J Natl Cancer Inst. 2019 Jul 1;111(7):646-654
pubmed: 30753567
Cell Rep. 2018 Jul 10;24(2):379-390.e6
pubmed: 29996099
Nat Commun. 2017 Jul 17;8:16073
pubmed: 28714465
J Immunother Cancer. 2019 Sep 18;7(1):255
pubmed: 31533831
Leukemia. 2021 Aug;35(8):2274-2284
pubmed: 33526858
J Immunother Cancer. 2021 Aug;9(8):
pubmed: 34452929
Clin Cancer Res. 2022 Mar 01;28(5):882-892
pubmed: 34844977
Sci Transl Med. 2014 Apr 16;6(232):232ra51
pubmed: 24739759
Theranostics. 2018 Nov 12;8(21):5842-5854
pubmed: 30613266
EBioMedicine. 2019 Sep;47:235-246
pubmed: 31462392
Clin Cancer Res. 2018 Mar 15;24(6):1287-1295
pubmed: 29298798
J Immunother Cancer. 2019 Apr 29;7(1):115
pubmed: 31036082
Exp Hematol Oncol. 2022 Jun 20;11(1):38
pubmed: 35725570
Mol Cancer. 2023 Jan 30;22(1):20
pubmed: 36717905
Science. 1997 Nov 28;278(5343):1623-6
pubmed: 9374462
Annu Rev Immunol. 2006;24:147-74
pubmed: 16551246
Immunology. 2009 Sep;128(1 Suppl):e837-48
pubmed: 19740345
Nature. 2020 Aug;584(7822):624-629
pubmed: 32788723
Blood. 2010 Sep 9;116(10):1726-33
pubmed: 20519625
Cancer Res. 2014 Oct 15;74(20):5723-33
pubmed: 25164013
J Hematol Oncol. 2020 Jun 22;13(1):81
pubmed: 32571374
Biomark Res. 2022 Apr 25;10(1):24
pubmed: 35468841
Nat Commun. 2021 Aug 6;12(1):4746
pubmed: 34362900
Mol Ther. 2023 Mar 1;31(3):631-646
pubmed: 36463401
Blood. 2011 Apr 28;117(17):4467-75
pubmed: 21364193
Sci Immunol. 2022 Aug 12;7(74):eabn6563
pubmed: 35984893
Blood. 2009 Mar 12;113(11):2498-507
pubmed: 19056691
Cell. 2010 Sep 3;142(5):699-713
pubmed: 20813259
J Hematol Oncol. 2017 Mar 29;10(1):78
pubmed: 28356156
Elife. 2018 Jun 04;7:
pubmed: 29862966
J Hematol Oncol. 2023 Aug 18;16(1):97
pubmed: 37596653
Semin Immunopathol. 2021 Jun;43(3):423-438
pubmed: 34052871
Nat Rev Urol. 2021 Feb;18(2):79-92
pubmed: 33328650
N Engl J Med. 2020 Oct 1;383(14):1328-1339
pubmed: 32997907
Cancer Treat Rev. 2020 Jun;86:102019
pubmed: 32251926
Nat Rev Immunol. 2021 Aug;21(8):485-498
pubmed: 33526920
Eur J Immunol. 2016 Aug;46(8):1984-96
pubmed: 27325505
Theranostics. 2022 May 16;12(9):4221-4236
pubmed: 35673564
Gastroenterology. 2015 Jun;148(7):1383-91.e6
pubmed: 25747273
Cell Mol Immunol. 2021 Sep;18(9):2083-2100
pubmed: 34267335
Int J Cancer. 2002 Nov 10;102(2):159-65
pubmed: 12385012
J Clin Invest. 2019 Mar 12;129(5):2094-2106
pubmed: 30860984
Sci Immunol. 2022 Jan 21;7(67):eabj5501
pubmed: 35061505
Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6742-7
pubmed: 19346489
Cell Mol Immunol. 2017 Sep;14(9):748-757
pubmed: 26972770
Clin Transl Immunology. 2022 Jan 10;11(1):e1367
pubmed: 35028137
Biomark Res. 2022 Nov 23;10(1):86
pubmed: 36419115
Clin Cancer Res. 2015 Mar 1;21(5):1115-26
pubmed: 25316820
Proc Natl Acad Sci U S A. 2014 Sep 30;111(39):14211-6
pubmed: 25225409
Cancer Res. 2011 Apr 1;71(7):2664-74
pubmed: 21324923
Blood. 2010 Jan 14;115(2):274-81
pubmed: 19897577
Nature. 2019 Aug;572(7769):392-396
pubmed: 31367043
Cancer Res. 2017 Jul 1;77(13):3655-3665
pubmed: 28455419
Front Immunol. 2021 Jun 02;12:645131
pubmed: 34149689
J Biol Chem. 1995 Mar 3;270(9):4689-96
pubmed: 7876240
Cell Death Dis. 2021 Sep 27;12(10):882
pubmed: 34580284
Cell Rep. 2015 Sep 22;12(11):1902-14
pubmed: 26365184
Oncotarget. 2016 Feb 16;7(7):7842-55
pubmed: 26556868
Adv Sci (Weinh). 2019 Jul 22;6(18):1901278
pubmed: 31559140
Nat Med. 2020 Jun;26(6):878-885
pubmed: 32451495
Nat Commun. 2023 Apr 20;14(1):2266
pubmed: 37080958
Cancer Cell. 2017 Dec 11;32(6):869-883.e5
pubmed: 29232557
J Clin Invest. 2014 Dec;124(12):5305-16
pubmed: 25384219
Oncoimmunology. 2020 Jun 2;9(1):1771143
pubmed: 32934877
J Hematol Oncol. 2020 Nov 11;13(1):153
pubmed: 33176869
Immunology. 2011 May;133(1):62-73
pubmed: 21320123
J Immunol. 2010 Mar 15;184(6):3260-8
pubmed: 20154204
Nat Nanotechnol. 2017 Jul;12(7):692-700
pubmed: 28650441
Br J Haematol. 2018 Jun;181(6):837-840
pubmed: 28439879
Cancer Immunol Immunother. 2014 Aug;63(8):847-57
pubmed: 24878890
Annu Rev Immunol. 2009;27:451-83
pubmed: 19105661
Cancer Biol Ther. 2007 Aug;6(8):1206-10
pubmed: 17617742
Mol Immunol. 2015 Jan;63(1):113-24
pubmed: 24698842
Semin Immunol. 2021 Feb;52:101481
pubmed: 34023170
Exp Hematol Oncol. 2022 Nov 16;11(1):100
pubmed: 36384590
J Clin Oncol. 2022 Oct 10;40(29):3383-3393
pubmed: 35452273
Immunol Invest. 2012;41(6-7):635-57
pubmed: 23017139
Exp Hematol Oncol. 2022 Apr 23;11(1):24
pubmed: 35461288
Biochim Biophys Acta Rev Cancer. 2022 Sep;1877(5):188771
pubmed: 35931392
J Immunother Cancer. 2022 Apr;10(4):
pubmed: 35379738
PLoS One. 2010 Jan 27;5(1):e8922
pubmed: 20111717
Cancer Lett. 2018 Nov 28;437:25-34
pubmed: 30165193
Sci Transl Med. 2019 Dec 4;11(521):
pubmed: 31801883
Cell Mol Immunol. 2021 Jul;18(7):1652-1661
pubmed: 33980993
N Engl J Med. 2020 Feb 6;382(6):545-553
pubmed: 32023374
Cancer Res. 2005 Oct 15;65(20):9525-35
pubmed: 16230418
Otolaryngol Head Neck Surg. 1992 Jan;106(1):27-33
pubmed: 1734363
Clin Cancer Res. 2020 Mar 15;26(6):1420-1431
pubmed: 31848188
Mol Cancer. 2017 Aug 15;16(1):137
pubmed: 28810877
Annu Rev Immunol. 2013;31:51-72
pubmed: 23157435
Trends Immunol. 2013 Dec;34(12):573-82
pubmed: 24055329
Pharmacol Ther. 2021 Mar;219:107709
pubmed: 33091428
J Immunol. 2015 Sep 1;195(5):2483-92
pubmed: 26216891
Cancer Med. 2018 Mar;7(3):690-697
pubmed: 29468834
Nat Rev Cancer. 2020 Oct;20(10):594-607
pubmed: 32678342
Asia Pac J Clin Oncol. 2018 Oct;14(5):e243-e251
pubmed: 29532611
Biomedicines. 2022 Nov 24;10(12):
pubmed: 36551788
J Leukoc Biol. 2017 Oct;102(4):1003-1016
pubmed: 28642280
Nature. 2011 May 19;473(7347):298-307
pubmed: 21593862
Lancet Haematol. 2021 Nov;8(11):e808-e817
pubmed: 34627593
Cancer Immunol Res. 2018 Dec;6(12):1561-1577
pubmed: 30341213
Nature. 2015 Jun 18;522(7556):349-53
pubmed: 25985180
Adv Exp Med Biol. 2020;1273:159-173
pubmed: 33119881
Blood Adv. 2019 Mar 12;3(5):813-824
pubmed: 30858151
Immunotherapy. 2017 Jan;9(2):115-121
pubmed: 28128709
Cancer Immunol Immunother. 2007 Aug;56(8):1285-97
pubmed: 17265022
Cell. 2021 Apr 15;184(8):2033-2052.e21
pubmed: 33765443
Lancet Oncol. 2022 Jun;23(6):781-792
pubmed: 35576957
J Cell Sci. 2010 Oct 1;123(Pt 19):3347-56
pubmed: 20826457
Cancer Res. 2016 Apr 1;76(7):1792-803
pubmed: 26873846
Cancer Immunol Res. 2016 Nov;4(11):983-994
pubmed: 27697858
Nat Rev Cancer. 2022 Oct;22(10):557-575
pubmed: 35879429
Expert Opin Drug Deliv. 2021 Oct;18(10):1335-1354
pubmed: 33896323
Front Immunol. 2020 Feb 13;11:167
pubmed: 32117298
Clin Cancer Res. 2017 Sep 1;23(17):5034-5043
pubmed: 28536308
Front Immunol. 2015 Jun 10;6:266
pubmed: 26113846
Cancer Immunol Res. 2015 Nov;3(11):1236-47
pubmed: 26025381
Front Med (Lausanne). 2022 May 09;9:897750
pubmed: 35615083
J Leukoc Biol. 2003 Dec;74(6):1026-34
pubmed: 12960256
Trends Immunol. 2017 Aug;38(8):577-593
pubmed: 28610825
Nat Commun. 2018 Aug 15;9(1):3261
pubmed: 30111884
J Transl Med. 2018 May 29;16(1):142
pubmed: 29843811
Clin Cancer Res. 2016 Apr 15;22(8):1897-906
pubmed: 27084743
Nat Med. 2013 Oct;19(10):1264-72
pubmed: 24056773
Blood. 2011 Aug 25;118(8):2254-65
pubmed: 21734236
Int J Mol Sci. 2022 Dec 19;23(24):
pubmed: 36555840
J Control Release. 2020 Dec 10;328:395-406
pubmed: 32853733
Nat Biotechnol. 2020 Aug;38(8):947-953
pubmed: 32361713
Biochim Biophys Acta Rev Cancer. 2021 Jan;1875(1):188499
pubmed: 33385485
Oncogene. 2018 Aug;37(33):4546-4561
pubmed: 29743594
Cancer Immunol Immunother. 2013 May;62(5):909-18
pubmed: 23589106
Nature. 2019 Oct;574(7776):45-56
pubmed: 31578484
Cell Immunol. 2020 Jul;353:104119
pubmed: 32446032
Front Immunol. 2012 Oct 15;3:319
pubmed: 23087693
Clin Cancer Res. 2017 May 15;23(10):2442-2450
pubmed: 27810904
Cell Death Dis. 2020 Apr 16;11(4):234
pubmed: 32300100
Cancer Immunol Immunother. 2009 Jan;58(1):49-59
pubmed: 18446337
Biomater Sci. 2022 Mar 2;10(5):1193-1208
pubmed: 35122479
Blood. 1996 Apr 1;87(7):2632-40
pubmed: 8639878
Front Immunol. 2023 Jul 13;14:1196970
pubmed: 37520520
Cancer Res Treat. 2019 Jan;51(1):252-266
pubmed: 29690747
J Cell Physiol. 2018 Apr;233(4):3024-3036
pubmed: 28661031
Clin Cancer Res. 2012 Dec 15;18(24):6748-57
pubmed: 22767669
Anticancer Agents Med Chem. 2014 Feb;14(2):204-10
pubmed: 24237220
Oncoimmunology. 2013 Feb 1;2(2):e23038
pubmed: 23524684
Oncoimmunology. 2022 Dec 15;12(1):2147317
pubmed: 36531687
Cancer Cell. 2011 Apr 12;19(4):541-55
pubmed: 21481794
Nature. 2015 Mar 19;519(7543):366-9
pubmed: 25762141
Exp Hematol Oncol. 2022 Jul 19;11(1):43
pubmed: 35854339
Nat Immunol. 2003 Oct;4(10):974-81
pubmed: 12949532
J Immunol. 2011 Nov 15;187(10):4927-33
pubmed: 22049227
Cancer Gene Ther. 2006 Apr;13(4):393-405
pubmed: 16224496
Adv Drug Deliv Rev. 2009 Mar 28;61(3):195-204
pubmed: 19211030
Chem Soc Rev. 2013 Jun 21;42(12):4859-66
pubmed: 23503527
Immunity. 2021 May 11;54(5):875-884
pubmed: 33979585
JCI Insight. 2019 Nov 14;4(22):
pubmed: 31600167
Mol Cancer. 2019 Mar 30;18(1):60
pubmed: 30925919
World Allergy Organ J. 2016 Feb 11;9:7
pubmed: 26904159
J Exp Med. 2006 Apr 17;203(4):1033-43
pubmed: 16606675
Cancer Immunol Res. 2021 Jun;9(6):612-623
pubmed: 33674358
Front Immunol. 2019 Aug 29;10:2078
pubmed: 31555287
Proc Natl Acad Sci U S A. 2005 Mar 15;102(11):4185-90
pubmed: 15753302
Oncogene. 2020 Apr;39(16):3292-3304
pubmed: 32071396
Cancer Res. 2014 Dec 15;74(24):7250-9
pubmed: 25377469
Lancet. 2019 Dec 7;394(10214):2096-2107
pubmed: 31735560
Clin Cancer Res. 2015 Jan 1;21(1):39-48
pubmed: 25320361
Cell Res. 2017 Aug;27(8):1034-1045
pubmed: 28685773
Trends Immunol. 2012 Mar;33(3):119-26
pubmed: 22277903
Mol Cancer. 2022 Sep 26;21(1):184
pubmed: 36163047
Proc Natl Acad Sci U S A. 2005 May 3;102(18):6467-72
pubmed: 15840716
Lancet Oncol. 2021 Dec;22(12):1740-1751
pubmed: 34793719
Trends Immunol. 2011 Aug;32(8):364-72
pubmed: 21752715
Clin Cancer Res. 2014 Aug 1;20(15):4096-106
pubmed: 24907113
J Thorac Oncol. 2020 Jul;15(7):1210-1222
pubmed: 32173464
Immunol Rev. 2017 Mar;276(1):40-51
pubmed: 28258701
J Immunother Cancer. 2021 Dec;9(12):
pubmed: 34916256
J Hematol Oncol. 2021 May 1;14(1):73
pubmed: 33933160
J Immunol. 2018 Jul 1;201(1):278-295
pubmed: 29752311
Sci Transl Med. 2022 Nov 2;14(669):eabj1270
pubmed: 36322632
Clin Exp Allergy. 2010 Apr;40(4):563-75
pubmed: 20447076
Br J Cancer. 2004 Oct 4;91(7):1316-26
pubmed: 15365564
Am J Pathol. 2020 Jan;190(1):222-233
pubmed: 31654638
Mol Cancer. 2022 Jan 14;21(1):15
pubmed: 35031075
J Immunother Cancer. 2021 Jun;9(6):
pubmed: 34168004
Cell Discov. 2018 Nov 20;4:62
pubmed: 30479831
Immunity. 2020 Dec 15;53(6):1215-1229.e8
pubmed: 33220234
Cytokine Growth Factor Rev. 2021 Jun;59:36-45
pubmed: 33495094
Cancer Treat Rev. 2022 Nov;110:102461
pubmed: 36058143
J Clin Invest. 2014 Jun;124(6):2626-39
pubmed: 24789911
Nat Immunol. 2022 Sep;23(9):1309-1316
pubmed: 36002647
Cancer Immunol Res. 2017 Jan;5(1):3-8
pubmed: 28052991
Cancer Res. 2021 Feb 1;81(3):671-684
pubmed: 33203700
Nat Med. 2004 Sep;10(9):942-9
pubmed: 15322536
Cancer Cell. 2014 Nov 10;26(5):638-52
pubmed: 25446897
Clin Cancer Res. 2020 Sep 15;26(18):4921-4932
pubmed: 32646922
J Immunol. 2003 Dec 15;171(12):6457-65
pubmed: 14662845
Nat Immunol. 2011 Sep 11;12(10):949-58
pubmed: 21909092
Cancer Prev Res (Phila). 2014 Aug;7(8):835-44
pubmed: 24866179
Front Immunol. 2022 Apr 07;13:847008
pubmed: 35464442
Int Immunol. 2010 Oct;22(10):839-49
pubmed: 20739459
Annu Rev Med. 2017 Jan 14;68:139-152
pubmed: 27860544
PLoS Med. 2015 Mar 03;12(3):e1001796
pubmed: 25734483
Cell Metab. 2020 Jan 7;31(1):148-161.e5
pubmed: 31761565
JAMA Netw Open. 2019 May 3;2(5):e192535
pubmed: 31050774
J Exp Med. 2009 Jun 8;206(6):1327-37
pubmed: 19451266
J Hematol Oncol. 2019 Aug 28;12(1):86
pubmed: 31462327
Cell Mol Immunol. 2020 Aug;17(8):807-821
pubmed: 32612154
Clin Cancer Res. 2015 Jan 1;21(1):30-8
pubmed: 25564570
Nat Rev Clin Oncol. 2016 Mar;13(3):143-58
pubmed: 26598942
Clin Cancer Res. 2017 Nov 15;23(22):6764-6770
pubmed: 28663235
Exp Hematol Oncol. 2022 Nov 16;11(1):99
pubmed: 36384979
J Control Release. 2016 Feb 28;224:103-111
pubmed: 26772876
Immunity. 2020 Jun 16;52(6):1075-1087.e8
pubmed: 32445619
J Hematol Oncol. 2022 Aug 17;15(1):110
pubmed: 35978372
Nat Immunol. 2018 Jul;19(7):723-732
pubmed: 29915296
J Immunother Cancer. 2020 Jun;8(1):
pubmed: 32601081
Annu Rev Immunol. 2021 Apr 26;39:583-609
pubmed: 33637019
Adv Exp Med Biol. 2020;1224:117-140
pubmed: 32036608
J Exp Med. 2019 Oct 7;216(10):2394-2411
pubmed: 31375534
Cancer Res. 2018 Apr 1;78(7):1685-1699
pubmed: 29363545
Cancer Immunol Immunother. 2018 Sep;67(9):1355-1364
pubmed: 29968153
Int J Cancer. 2017 May 15;140(10):2321-2330
pubmed: 28177522
Int J Cancer. 2004 Apr 10;109(3):402-11
pubmed: 14961579
Int Immunol. 2001 Apr;13(4):459-63
pubmed: 11282985
Cancer Res. 2017 May 15;77(10):2735-2745
pubmed: 28249897
Blood. 2009 Apr 2;113(14):3218-25
pubmed: 19141859
Chem Immunol Allergy. 2014;100:172-92
pubmed: 24925398
J Clin Invest. 2009 Jun;119(6):1524-36
pubmed: 19411762
Cold Spring Harb Perspect Biol. 2013 Feb 01;5(2):
pubmed: 23378590
Cell Mol Immunol. 2020 Sep;17(9):925-939
pubmed: 32699351
J Hematol Oncol. 2021 Nov 22;14(1):199
pubmed: 34809678
J Clin Oncol. 2007 Mar 1;25(7):876-83
pubmed: 17327609
Cancer Discov. 2021 Jan;11(1):34-44
pubmed: 33277307
Nat Med. 2014 Jun;20(6):676-81
pubmed: 24859530
J Clin Invest. 2016 Mar 1;126(3):799-808
pubmed: 26928033
J Allergy Clin Immunol. 2000 Apr;105(4):651-63
pubmed: 10756213
Free Radic Res. 2010 May;44(5):479-96
pubmed: 20370557
J Intern Med. 2016 Jun;279(6):541-62
pubmed: 26748421
EMBO Mol Med. 2020 Oct 7;12(10):e11210
pubmed: 32885605
Immunol Rev. 2023 Mar;314(1):250-279
pubmed: 36504274
Glycobiology. 2018 Sep 1;28(9):640-647
pubmed: 29309569
J Immunol. 2009 Jul 15;183(2):937-44
pubmed: 19553533
BMC Cancer. 2010 Aug 30;10:464
pubmed: 20804550
Br J Cancer. 2019 Nov;121(10):837-845
pubmed: 31570753
Clin Transl Immunology. 2022 Feb 02;11(2):e1373
pubmed: 35136603
Oncogene. 2019 Jan;38(4):533-548
pubmed: 30158673
J Steroid Biochem Mol Biol. 2020 Apr;198:105557
pubmed: 31783150
JCI Insight. 2019 Apr 4;4(7):
pubmed: 30944253
Nat Commun. 2020 Nov 30;11(1):6119
pubmed: 33257678
J Exp Clin Cancer Res. 2022 Mar 31;41(1):119
pubmed: 35361234
Immunity. 2017 Nov 21;47(5):820-833
pubmed: 29166586
Cancer Biother Radiopharm. 2012 Oct;27(8):495-503
pubmed: 22746287
Cancer Immunol Immunother. 2013 Aug;62(8):1421-30
pubmed: 23764929
J Immunol. 2005 Jan 1;174(1):110-8
pubmed: 15611233
Adv Immunol. 2015;126:45-127
pubmed: 25727288
Nature. 2015 Jun 18;522(7556):345-348
pubmed: 25822788
J Immunol. 2010 Dec 15;185(12):7443-51
pubmed: 21068403
Oncoimmunology. 2016 Jun 27;5(8):e1200771
pubmed: 27622069
Clin Cancer Res. 2013 Mar 1;19(5):1035-43
pubmed: 23460534
J Immunother Cancer. 2021 Jul;9(7):
pubmed: 34301813
Haematologica. 2014 Jun;99(6):e81-3
pubmed: 24658821
Cells. 2023 Apr 19;12(8):
pubmed: 37190096
J Immunol. 2013 May 15;190(10):5216-25
pubmed: 23585680
Clin Cancer Res. 2011 Apr 1;17(7):1765-75
pubmed: 21233400
J Immunol. 2006 Nov 15;177(10):7322-31
pubmed: 17082651
Clin Cancer Res. 2019 Dec 1;25(23):7126-7138
pubmed: 31484667
Nat Rev Cancer. 2020 Aug;20(8):437-454
pubmed: 32581320
Semin Immunol. 2021 Apr;54:101510
pubmed: 34756806
J Immunother. 2008 Oct;31(8):771-80
pubmed: 18779742
Cancer Lett. 2015 Aug 10;364(2):106-17
pubmed: 25979231
Oncoimmunology. 2013 Apr 1;2(4):e23619
pubmed: 23734314
Cancer Immunol Immunother. 2013 Apr;62(4):747-60
pubmed: 23242316
Exp Hematol Oncol. 2019 Nov 29;8:32
pubmed: 31799063
Immunol Res. 2016 Aug;64(4):931-9
pubmed: 26832917
Curr Med Chem. 2016;23(7):650-66
pubmed: 26785997
Cancer Res. 2010 Apr 15;70(8):3052-61
pubmed: 20388795
Am J Clin Pathol. 2013 Dec;140(6):853-66
pubmed: 24225754
Blood. 2011 Jul 7;118(1):50-9
pubmed: 21566093
Front Immunol. 2021 Mar 10;12:647358
pubmed: 33777044
Clin Cancer Res. 2021 Feb 1;27(3):680-688
pubmed: 32958700
Mol Pharm. 2019 Apr 1;16(4):1714-1722
pubmed: 30860846
Cancer Res. 2017 Jan 15;77(2):291-302
pubmed: 27879269
Front Immunol. 2020 Jan 21;10:3038
pubmed: 32038612
Australas J Dermatol. 2020 Aug;61(3):e310-e318
pubmed: 32050042
PLoS One. 2016 Apr 19;11(4):e0153550
pubmed: 27092773
J Exp Med. 2009 Oct 26;206(11):2469-81
pubmed: 19808259
Proc Natl Acad Sci U S A. 1992 May 15;89(10):4285-9
pubmed: 1350088
J Hematol Oncol. 2021 Jul 23;14(1):115
pubmed: 34301270
Nat Rev Immunol. 2018 Nov;18(11):671-688
pubmed: 30209347
Cancers (Basel). 2021 Jan 08;13(2):
pubmed: 33430105
Cancer Res. 2011 Aug 1;71(15):5134-43
pubmed: 21697279
Cancer Res. 2006 Sep 15;66(18):9299-307
pubmed: 16982775
Cytokine Growth Factor Rev. 2016 Oct;31:61-71
pubmed: 27578214
Mol Cancer. 2019 Nov 6;18(1):155
pubmed: 31690319
Annu Rev Immunol. 2001;19:683-765
pubmed: 11244051
Signal Transduct Target Ther. 2021 Feb 23;6(1):75
pubmed: 33619259
J Immunol. 2009 Mar 1;182(5):2795-807
pubmed: 19234174
Clin Cancer Res. 2015 Dec 15;21(24):5453-9
pubmed: 26289067
Thyroid. 2016 Mar;26(3):381-9
pubmed: 26756227
Leukemia. 2018 Feb;32(2):520-531
pubmed: 28725044
Carcinogenesis. 2012 May;33(5):949-55
pubmed: 22425643
Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):E3562-70
pubmed: 25114209
Immunity. 2019 Apr 16;50(4):924-940
pubmed: 30995507
Immunity. 2005 Nov;23(5):491-502
pubmed: 16286017
Int J Mol Sci. 2021 Feb 05;22(4):
pubmed: 33562512
Cancer Discov. 2022 Sep 2;12(9):2140-2157
pubmed: 35771565
Cell Mol Life Sci. 2018 Jun;75(11):2045-2058
pubmed: 29184980
PLoS One. 2012;7(12):e50946
pubmed: 23284651
Allergy. 2005 Oct;60(10):1316-9
pubmed: 16135000
Cancer Biol Med. 2020 Feb 15;17(1):32-43
pubmed: 32296575
J Exp Med. 2013 Aug 26;210(9):1711-28
pubmed: 23897983
Clin Cancer Res. 2021 Mar 15;27(6):1744-1755
pubmed: 33451981
Sci Adv. 2020 Apr 29;6(18):eaaz6579
pubmed: 32494680
J Hematol Oncol. 2020 Nov 19;13(1):156
pubmed: 33213490
Blood. 1998 Dec 1;92(11):4150-66
pubmed: 9834220
Cancer Cell. 2004 Oct;6(4):409-21
pubmed: 15488763
Front Immunol. 2017 Apr 12;8:424
pubmed: 28446910
Int J Cancer. 2019 Jul 15;145(2):569-575
pubmed: 30414170
J Hematol Oncol. 2022 Aug 10;15(1):104
pubmed: 35948909
Cell. 2020 Dec 23;183(7):1826-1847.e31
pubmed: 33296702
Cancer Immunol Res. 2015 May;3(5):449-54
pubmed: 25691326
Annu Rev Med. 2020 Jan 27;71:47-58
pubmed: 31412220
Exp Hematol Oncol. 2021 May 10;10(1):31
pubmed: 33971970
J Hematol Oncol. 2021 Feb 16;14(1):27
pubmed: 33593403
Nat Med. 2002 Aug;8(8):793-800
pubmed: 12091876
Adv Mater. 2020 Oct;32(40):e2002054
pubmed: 32856350
Expert Opin Biol Ther. 2022 May;22(5):577-590
pubmed: 35037527
J Clin Oncol. 2010 Jul 20;28(21):3463-71
pubmed: 20547984
Biomark Res. 2021 Jan 6;9(1):1
pubmed: 33407885
EBioMedicine. 2022 Feb;76:103873
pubmed: 35152151
Nat Rev Drug Discov. 2018 Aug;17(8):588-606
pubmed: 30026524
Cancer Cell. 2009 Sep 8;16(3):183-94
pubmed: 19732719
Immunity. 2013 Mar 21;38(3):570-80
pubmed: 23434060
J Allergy Clin Immunol. 2019 Jul;144(1):312-315.e1
pubmed: 30857982
Exp Hematol Oncol. 2022 Jan 24;11(1):3
pubmed: 35074008
JAMA Oncol. 2023 Jan 1;9(1):112-121
pubmed: 36394838
Cancer Res. 1983 Jun;43(6):2997-3000
pubmed: 6850611
Immunity. 2020 May 19;52(5):856-871.e8
pubmed: 32289253
Cell. 2020 Apr 16;181(2):442-459.e29
pubmed: 32302573
Oncoimmunology. 2020 Apr 12;9(1):1747340
pubmed: 32313727
Oncoimmunology. 2017 May 16;6(9):e1326440
pubmed: 28932631
Clin Cancer Res. 2009 Aug 1;15(15):4857-66
pubmed: 19638467
Front Immunol. 2019 May 29;10:1181
pubmed: 31191545
Cell Rep Med. 2023 Mar 17;:100978
pubmed: 36933554
J Hematol Oncol. 2021 Apr 6;14(1):55
pubmed: 33823905
Biomed Pharmacother. 2015 Feb;69:374-9
pubmed: 25661385
N Engl J Med. 2015 Jul 2;373(1):23-34
pubmed: 26027431
Cancer Res. 2007 Jan 15;67(2):792-801
pubmed: 17234791
Cancer Immunol Res. 2016 Jul;4(7):592-9
pubmed: 27197061
Mol Aspects Med. 2023 Apr;90:101112
pubmed: 35948467
Cancer Cell. 2018 Oct 8;34(4):596-610.e11
pubmed: 30300581
J Mater Chem B. 2021 May 12;9(18):3892-3899
pubmed: 33928989
J Exp Med. 2020 Jul 6;217(7):
pubmed: 32369107
Cancer Immunol Immunother. 2019 Sep;68(9):1479-1492
pubmed: 31463653
Nat Nanotechnol. 2019 Mar;14(3):269-278
pubmed: 30664751
Cell Mol Immunol. 2019 May;16(5):430-441
pubmed: 30778167
Nat Rev Cancer. 2020 Apr;20(4):218-232
pubmed: 32024970
J Exp Med. 2021 Mar 1;218(3):
pubmed: 33416832
J Immunol. 2009 Apr 15;182(8):4499-506
pubmed: 19342621
J Hematol Oncol. 2019 Jul 12;12(1):76
pubmed: 31300030
Front Immunol. 2020 Sep 24;11:531491
pubmed: 33072086
Clin Cancer Res. 2018 Apr 15;24(8):1834-1844
pubmed: 29444931
J Exp Clin Cancer Res. 2020 Jul 11;39(1):132
pubmed: 32653013
Biomark Res. 2021 Oct 24;9(1):77
pubmed: 34689842
Biol Pharm Bull. 2005 Jun;28(6):1066-70
pubmed: 15930746
Cancers (Basel). 2021 Dec 24;14(1):
pubmed: 35008239
Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):1117-1122
pubmed: 28096371
Clin Rev Allergy Immunol. 2021 Oct;61(2):194-211
pubmed: 32740860
Blood. 2000 Feb 15;95(4):1207-13
pubmed: 10666192
Nat Immunol. 2012 Sep;13(9):832-42
pubmed: 22842346
J Exp Med. 2003 Jun 16;197(12):1667-76
pubmed: 12796469
Nat Commun. 2019 Sep 3;10(1):3974
pubmed: 31481662
Mol Cancer. 2022 Nov 1;21(1):206
pubmed: 36319998
Trends Immunol. 2016 Mar;37(3):208-220
pubmed: 26858199
Cancer Immunol Res. 2018 Nov;6(11):1375-1387
pubmed: 30143538
J Clin Oncol. 2005 Feb 10;23(5):999-1010
pubmed: 15598979
Clin Cancer Res. 2021 Jan 15;27(2):608-621
pubmed: 33148676
Blood. 2018 Jun 7;131(23):2515-2527
pubmed: 29463563
Front Immunol. 2016 Nov 11;7:492
pubmed: 27891129
Nat Commun. 2015 Jun 25;6:7458
pubmed: 26109379
Clin Cancer Res. 2016 Jun 15;22(12):2908-18
pubmed: 26787752
Sci Rep. 2016 Feb 01;6:20250
pubmed: 26833095
Sci Transl Med. 2021 Oct 20;13(616):eabj0835
pubmed: 34669444
Proc Natl Acad Sci U S A. 2019 Jan 22;116(4):1361-1369
pubmed: 30545915
Immunol Lett. 2019 May;209:28-35
pubmed: 30905824
Cancer Immunol Res. 2014 Nov;2(11):1051-8
pubmed: 25252722
Curr Opin Immunol. 2007 Feb;19(1):31-8
pubmed: 17126541
Cell Rep. 2018 Aug 21;24(8):1967-1976.e4
pubmed: 30134159
Gut. 2017 Nov;66(11):1900-1911
pubmed: 28274999
Oncogene. 2016 Nov 17;35(46):5931-5941
pubmed: 27086930
Int J Cancer. 2016 Aug 15;139(4):869-81
pubmed: 27062572
Int Rev Immunol. 2022;41(3):346-363
pubmed: 33118843
Immunity. 2021 Jul 13;54(7):1377-1391
pubmed: 34260886
Immunity. 2005 Mar;22(3):295-304
pubmed: 15780987
Cancer Res. 2016 Jun 1;76(11):3156-65
pubmed: 27197152
Nat Commun. 2020 Jun 2;11(1):2749
pubmed: 32488012
Immunity. 2013 Jul 25;39(1):1-10
pubmed: 23890059
Cell. 2018 Dec 13;175(7):1744-1755.e15
pubmed: 30503208
Biol Blood Marrow Transplant. 2017 Aug;23(8):1303-1310
pubmed: 28457953
Front Immunol. 2018 Sep 11;9:2052
pubmed: 30254636
Nat Rev Immunol. 2020 Mar;20(3):173-185
pubmed: 31676858
J Immunol. 2011 Jan 15;186(2):1218-27
pubmed: 21149605
J Leukoc Biol. 2012 Apr;91(4):591-8
pubmed: 22262799
Nat Rev Clin Oncol. 2022 May;19(5):342-355
pubmed: 35318469
J Immunother Cancer. 2021 Jul;9(7):
pubmed: 34301811
Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):14016-21
pubmed: 19666525
J Immunol. 2009 Feb 15;182(4):1818-28
pubmed: 19201833
Front Immunol. 2018 Oct 17;9:2410
pubmed: 30386347
Front Immunol. 2020 Sep 08;11:2103
pubmed: 33013885
Cancer Res. 2004 Sep 1;64(17):6337-43
pubmed: 15342423
Cancer Immunol Immunother. 2020 Sep;69(9):1929-1936
pubmed: 32435850
Blood. 2001 May 15;97(10):3146-51
pubmed: 11342442
Am J Cancer Res. 2021 Jan 01;11(1):79-91
pubmed: 33520361
J Clin Invest. 2013 Jul 1;:
pubmed: 23863628
Semin Immunol. 2019 Apr;42:101298
pubmed: 31604536
JCI Insight. 2022 Jun 8;7(11):
pubmed: 35471938
Immunology. 2020 Sep;161(1):28-38
pubmed: 32383173
J Exp Med. 2020 Dec 7;217(12):
pubmed: 32860704
Cancer Immunol Immunother. 2016 Apr;65(4):485-92
pubmed: 26559813
Nat Rev Immunol. 2002 Aug;2(8):557-68
pubmed: 12154375
Cells. 2022 Jan 27;11(3):
pubmed: 35159247
J Immunol. 2005 Feb 1;174(3):1338-47
pubmed: 15661891
Science. 2005 Jul 8;309(5732):264-8
pubmed: 15933162
Nat Commun. 2016 Jul 06;7:12150
pubmed: 27381735
Int J Biol Sci. 2018 Nov 28;14(14):2103-2113
pubmed: 30585273
Proc Natl Acad Sci U S A. 2011 Jul 26;108(30):12425-30
pubmed: 21746895
J Clin Invest. 2012 Mar;122(3):787-95
pubmed: 22378047
Int J Mol Sci. 2022 Apr 27;23(9):
pubmed: 35563215
Proc Natl Acad Sci U S A. 2011 Sep 6;108(36):14725-32
pubmed: 21825173
J Clin Invest. 2017 Jun 1;127(6):2176-2191
pubmed: 28436934
Proc Natl Acad Sci U S A. 2017 Feb 14;114(7):1637-1642
pubmed: 28137885
Trends Immunol. 2019 Apr;40(4):310-327
pubmed: 30890304
Oncoimmunology. 2018 Oct 31;8(2):e1537581
pubmed: 30713793
Eur J Immunol. 2018 Mar;48(3):532-542
pubmed: 29120053
Nat Med. 2019 Apr;25(4):656-666
pubmed: 30833750
Nat Immunol. 2007 Dec;8(12):1337-44
pubmed: 17965716
Blood. 2017 Apr 6;129(14):1991-2001
pubmed: 28143882
Nat Cancer. 2022 Jun;3(6):696-709
pubmed: 35637401
J Immunol. 2016 Oct 1;197(7):2715-25
pubmed: 27566820
DNA Cell Biol. 2004 Sep;23(9):549-60
pubmed: 15383175
Clin Immunol. 2013 Oct;149(1):55-64
pubmed: 23891738
Oncoimmunology. 2016 Nov 22;5(12):e1250051
pubmed: 28123890
Blood Cancer J. 2021 Aug 14;11(8):146
pubmed: 34392311
Cancer Cell. 2014 Nov 10;26(5):623-37
pubmed: 25446896
Blood. 2010 Sep 30;116(13):2286-94
pubmed: 20460501
EBioMedicine. 2020 Sep;59:102975
pubmed: 32853984
J Hematol Oncol. 2019 Dec 9;12(1):134
pubmed: 31815659
N Engl J Med. 2010 Jul 29;363(5):411-22
pubmed: 20818862
Cancer Immunol Res. 2020 Jan;8(1):120-130
pubmed: 31690649
Cancer Gene Ther. 2004 Apr;11(4):280-8
pubmed: 15002032
Nat Immunol. 2016 Jun 21;17(7):758-64
pubmed: 27328005
Science. 2020 Aug 21;369(6506):
pubmed: 32820094
Cell Metab. 2019 Jul 2;30(1):36-50
pubmed: 31269428
Sci Rep. 2021 Oct 26;11(1):21133
pubmed: 34702850
Clin Cancer Res. 2019 Mar 15;25(6):1867-1879
pubmed: 30446590
Leukemia. 2017 Oct;31(10):2172-2180
pubmed: 28096534
Br J Cancer. 2014 Sep 23;111(7):1350-62
pubmed: 25101565
Leukemia. 2005 Apr;19(4):551-6
pubmed: 15744356
Cancer Res. 2018 Apr 1;78(7):1779-1791
pubmed: 29374065
Front Immunol. 2020 Sep 30;11:573920
pubmed: 33101298
Int J Biol Sci. 2016 Jan 28;12(3):302-13
pubmed: 26929737
Signal Transduct Target Ther. 2022 Jun 29;7(1):205
pubmed: 35768424
Nat Med. 2020 May;26(5):688-692
pubmed: 32405062
Proc Natl Acad Sci U S A. 2019 Oct 22;116(43):21704-21714
pubmed: 31591235
Cancer Cell. 2023 Jan 9;41(1):106-123.e10
pubmed: 36525971
Cell. 2009 Jul 23;138(2):286-99
pubmed: 19632179
Cell Rep. 2020 Apr 7;31(1):107492
pubmed: 32268090
Gastroenterology. 2022 Dec;163(6):1593-1612
pubmed: 35948109
Med Oncol. 2022 Dec 2;40(1):29
pubmed: 36460881
Front Immunol. 2016 Dec 21;7:629
pubmed: 28066438
J Exp Med. 2021 Jul 5;218(7):
pubmed: 33974041
Cell Metab. 2016 Nov 8;24(5):701-715
pubmed: 27773694
Cells. 2022 Jan 20;11(3):
pubmed: 35159157
Immunity. 2014 Jul 17;41(1):49-61
pubmed: 25035953
J Leukoc Biol. 2017 Aug;102(2):343-349
pubmed: 28264904
Cell Rep. 2017 Oct 3;21(1):154-167
pubmed: 28978469
Trends Immunol. 2015 Apr;36(4):240-9
pubmed: 25770923
J Immunol. 2012 Dec 15;189(12):5602-11
pubmed: 23152559
Int J Surg. 2022 Nov;107:106959
pubmed: 36265780
J Hematol Oncol. 2022 May 18;15(1):61
pubmed: 35585567
J Immunother Cancer. 2022 Mar;10(3):
pubmed: 35338085
J Allergy Clin Immunol. 2009 May;123(5):1142-9, 1149.e1-5
pubmed: 19275959
Cell Mol Immunol. 2023 May;20(5):432-447
pubmed: 36949244
Gastroenterology. 2014 Dec;147(6):1393-404
pubmed: 25181692
Nat Commun. 2021 Feb 9;12(1):877
pubmed: 33563975
J Immunother Cancer. 2019 Apr 24;7(1):113
pubmed: 31014399
Immunity. 2018 Mar 20;48(3):453-473
pubmed: 29562195
Ann Oncol. 2017 Dec 1;28(suppl_12):xii44-xii55
pubmed: 28945841
Nat Cancer. 2020 Jul;1(7):681-691
pubmed: 35122038
Cancer Prev Res (Phila). 2010 Oct;3(10):1314-33
pubmed: 20736334
J Natl Cancer Inst. 2015 Dec 06;108(5):
pubmed: 26640245
J Hematol Oncol. 2021 Apr 19;14(1):65
pubmed: 33874996
Am J Respir Crit Care Med. 2015 May 1;191(9):1001-11
pubmed: 25695403
Cancer Lett. 2019 Sep 10;459:204-215
pubmed: 31199988
Physiol Rev. 2019 Apr 1;99(2):1223-1248
pubmed: 30758246
Crit Rev Food Sci Nutr. 2019;59(sup1):S71-S80
pubmed: 30277803
Leukemia. 2003 Jun;17(6):1068-77
pubmed: 12764370
Front Immunol. 2021 Dec 01;12:732135
pubmed: 34925314
Clin Cancer Res. 2018 Nov 15;24(22):5552-5561
pubmed: 30045932
J Exp Med. 2016 Jan 11;213(1):15-23
pubmed: 26694970
J Immunol. 2017 Aug 1;199(3):855-865
pubmed: 28652400
Cytokine Growth Factor Rev. 2015 Dec;26(6):647-57
pubmed: 26115564
Mol Cancer. 2022 Jan 21;21(1):28
pubmed: 35062949
Sci Transl Med. 2016 Apr 13;8(334):334ra52
pubmed: 27075626
J Leukoc Biol. 2015 Dec;98(6):913-22
pubmed: 26337512
Nat Commun. 2020 Sep 24;11(1):4835
pubmed: 32973173
Lancet. 2022 May 7;399(10337):1790-1798
pubmed: 35483400
Life Sci. 2021 Jan 1;264:118699
pubmed: 33137368
Oncogene. 2010 Nov 25;29(47):6203-15
pubmed: 20729915
Cytokine Growth Factor Rev. 2022 Oct;67:49-57
pubmed: 35871139
J Exp Med. 2004 May 3;199(9):1213-21
pubmed: 15123743
Signal Transduct Target Ther. 2021 Jan 20;6(1):26
pubmed: 33473101
J Transl Med. 2013 Dec 17;11:314
pubmed: 24341512
Exp Hematol Oncol. 2021 Dec 29;10(1):60
pubmed: 34965886
Oncotarget. 2017 Apr 6;8(31):51024-51036
pubmed: 28881626
Nature. 2015 Jan 15;517(7534):293-301
pubmed: 25592534
Exp Hematol Oncol. 2021 Jun 10;10(1):36
pubmed: 34112250
J Immunol. 2008 Jul 1;181(1):776-84
pubmed: 18566444
Cancer Lett. 2019 Jan;440-441:116-125
pubmed: 30343113
Exp Hematol Oncol. 2022 Sep 29;11(1):67
pubmed: 36175988
Exp Hematol Oncol. 2018 Nov 16;7:28
pubmed: 30473928
Cancer Immunol Immunother. 2004 Jun;53(6):543-50
pubmed: 14666382
Nat Immunol. 2020 Aug;21(8):835-847
pubmed: 32690952
Cells. 2020 May 22;9(5):
pubmed: 32456078
Blood. 2005 Aug 15;106(4):1278-85
pubmed: 15878980
Int Immunopharmacol. 2018 Oct;63:282-291
pubmed: 30121453
J Biol Chem. 2007 May 18;282(20):15238-47
pubmed: 17384413
Nat Rev Drug Discov. 2022 Nov;21(11):799-820
pubmed: 35974096
Proc Natl Acad Sci U S A. 2011 Nov 8;108(45):18342-7
pubmed: 22042861
Nat Rev Cancer. 2008 Aug;8(8):618-31
pubmed: 18633355
Cancer Cell. 2021 Jun 14;39(6):725-729
pubmed: 34129817
Cancer Res. 2014 Mar 1;74(5):1349-60
pubmed: 24448235
Cancers (Basel). 2021 Mar 25;13(7):
pubmed: 33805904
Front Immunol. 2022 Dec 19;13:1061394
pubmed: 36601124
Blood. 2011 Nov 3;118(18):4863-71
pubmed: 21911833
J Hematol Oncol. 2023 Feb 8;16(1):8
pubmed: 36755342
Clin Cancer Res. 2017 Sep 15;23(18):5358-5365
pubmed: 28539464
J Hematol Oncol. 2022 Oct 8;15(1):142
pubmed: 36209176
Cancer Cell. 2014 Jun 16;25(6):846-59
pubmed: 24898549
Nat Immunol. 2013 Oct;14(10):1014-22
pubmed: 24048123
Clin Sci (Lond). 2011 Jun;120(11):473-84
pubmed: 21320076
Trends Cancer. 2019 Dec;5(12):822-834
pubmed: 31813459
Cancer Immunol Immunother. 2019 Sep;68(9):1417-1428
pubmed: 31422446
Proc Natl Acad Sci U S A. 2009 Nov 17;106(46):19455-60
pubmed: 19892741
Oncoimmunology. 2012 Aug 1;1(5):780-782
pubmed: 22934281
Immunity. 2013 Sep 19;39(3):611-21
pubmed: 24012420
Nature. 2015 Jul 9;523(7559):231-5
pubmed: 25970248
J Hematol Oncol. 2022 Apr 29;15(1):46
pubmed: 35488312
Eur Respir J. 2010 Mar;35(3):564-70
pubmed: 19643947
Trends Cell Biol. 2023 Mar;33(3):189-203
pubmed: 35931610
Cancer Immunol Immunother. 2017 Oct;66(10):1345-1357
pubmed: 28608115
Immunity. 2021 Jun 8;54(6):1154-1167.e7
pubmed: 33979578
J Immunol. 2006 Jan 1;176(1):309-18
pubmed: 16365423
J Immunol. 2004 Jan 15;172(2):1227-36
pubmed: 14707101
Lancet Oncol. 2014 Feb;15(2):e58-68
pubmed: 24480556
J Immunother Cancer. 2022 Sep;10(9):
pubmed: 36162920
Proc Natl Acad Sci U S A. 2013 Jul 2;110(27):11103-8
pubmed: 23690610
Cancer Res. 2021 Apr 1;81(7):1788-1801
pubmed: 33483371
Clin Transl Med. 2020 Feb 10;9(1):6
pubmed: 32037496
Eur J Cancer. 2020 Dec;141:162-170
pubmed: 33161240
Nucleic Acids Res. 2012 Oct;40(19):e150
pubmed: 22753106
Blood. 2020 Feb 6;135(6):399-410
pubmed: 31856277
Clin Cancer Res. 2021 May 1;27(9):2383-2393
pubmed: 33376096
Cancer Immunol Res. 2014 Jan;2(1):80-90
pubmed: 24778163
Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5561-6
pubmed: 11929985
Mol Cancer. 2013 Dec 09;12(1):154
pubmed: 24321240
Immunobiology. 2008;213(5):417-26
pubmed: 18472050
J Hematol Oncol. 2019 Apr 1;12(1):35
pubmed: 30935414
Blood. 2013 Apr 11;121(15):2836-44
pubmed: 23390195
R Soc Open Sci. 2022 Feb 2;9(2):210705
pubmed: 35127110
Nat Rev Cancer. 2016 Jul;16(7):431-46
pubmed: 27282249
Clin Cancer Res. 2022 Jul 15;28(14):3053-3065
pubmed: 35536547
Oncoimmunology. 2018 Dec 13;8(3):1554967
pubmed: 30723587
Nat Biotechnol. 2017 Aug;35(8):765-772
pubmed: 28504668
Int J Cancer. 1991 May 10;48(2):227-33
pubmed: 1826900
Gene Ther. 2005 Jan;12(2):129-39
pubmed: 15483669
Cancer Immunol Immunother. 2012 Jun;61(6):827-38
pubmed: 22080405
Cancer Treat Rev. 2017 Nov;60:24-31
pubmed: 28866366
Cancer Immunol Res. 2020 Jan;8(1):57-69
pubmed: 31719055
BMC Med. 2020 Nov 20;18(1):360
pubmed: 33213430
Oncoimmunology. 2014 Aug 03;3(8):e954471
pubmed: 25610747
Cancer Immunol Res. 2015 Jun;3(6):575-82
pubmed: 26041808
Sci Transl Med. 2020 Nov 4;12(568):
pubmed: 33148626
Mol Ther Oncolytics. 2020 May 04;17:421-430
pubmed: 32462079
Biochem Pharmacol. 2021 Jan;183:114354
pubmed: 33279498
J Transl Med. 2015 Jun 03;13:175
pubmed: 26695182
Cancer Res. 2005 Oct 1;65(19):8896-904
pubmed: 16204061
Trends Mol Med. 2013 Jun;19(6):355-67
pubmed: 23601906
J Immunol. 2009 Jan 1;182(1):240-9
pubmed: 19109155
Proc Natl Acad Sci U S A. 2021 Jun 29;118(26):
pubmed: 34155121
PLoS One. 2018 Jun 28;13(6):e0199740
pubmed: 29953504
Mol Ther. 2012 Sep;20(9):1664-75
pubmed: 22735380
Cell. 2018 Feb 22;172(5):1022-1037.e14
pubmed: 29429633
Radiother Oncol. 2015 Sep;116(3):438-42
pubmed: 26138057
Blood. 2010 Sep 30;116(13):2277-85
pubmed: 20566893
Blood. 2019 May 16;133(20):2159-2167
pubmed: 30898857
Cancer Immunol Immunother. 2012 Sep;61(9):1527-34
pubmed: 22706380
FASEB J. 2003 Jul;17(10):1195-214
pubmed: 12832285
Eur J Cancer. 2022 Jul;169:20-31
pubmed: 35490565
Immunity. 2018 Dec 18;49(6):1148-1161.e7
pubmed: 30552023
Int J Mol Sci. 2018 Aug 11;19(8):
pubmed: 30103488
Cancer Cell. 2023 Jan 9;41(1):9-11
pubmed: 36525972
Nat Med. 2001 Jan;7(1):94-100
pubmed: 11135622
Clin Cancer Res. 2005 Oct 15;11(20):7322-7
pubmed: 16243803
Cell Rep. 2018 Mar 13;22(11):3006-3020
pubmed: 29539427
Int J Cancer. 2019 Jan 1;144(1):136-149
pubmed: 30121947
Mol Med Rep. 2019 Mar;19(3):2330-2340
pubmed: 30664202
Nat Rev Immunol. 2012 Mar 22;12(4):253-68
pubmed: 22437938
Clin Cancer Res. 2019 Aug 15;25(16):5002-5014
pubmed: 30837276